HEPHAISTOS-Pharma Competitors and Similar CompaniesClear all
HEPHAISTOS-Pharma's competitors and similar companies include Aravive, Gamida Cell, OncoDNA and A2 Biotherapeutics.
 HEPHAISTOS-Pharma HEPHAISTOS-Pharma is a biotechnology company developing anti-tumor immunotherapies. |  Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. |  Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. |  OncoDNA OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients. |  A2 Biotherapeutics A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients. | |
Founding Date | Founding Date 2018 | Founding Date 2008 | Founding Date 1998 | Founding Date 2012 | Founding Date 2018 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Orsay, FR HQ | Locations Houston, US HQ | Locations Boston, US HQ Jerusalem, IL | Locations Charleroi, BE HQ | Locations Agoura Hills, US HQ |
Employees | Employees 15 | Employees 23 | Employees 143175% increase | Employees 502% increase | Employees 1255% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.9 m | Valuation ($) 4.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) $1.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($76.3m) (FY, 2022) | Net income ($63m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 20.6m (over 6 years ago) | Latest funding round $ 71.5m (over 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 128.3m | Total funding raised $ 29.8m | Total funding raised $ 128.5m |
For sources of this data, please see the company profile
View Company Profiles
Aravive
HQ
Houston, US
Employees
23
Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.
View companyGamida Cell
HQ
Boston, US
Employees
143
Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
View companyOncoDNA
HQ
Charleroi, BE
Employees
50↑ 2% increase
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
View companyA2 Biotherapeutics
HQ
Agoura Hills, US
Employees
125↓ 5% decrease
A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients.
View company